Diclofenac Sodium SR Pellets (CAS No: 15307-79-6)
Pharmaceutical-Grade Sustained Release Pellets for Oral Dosage Forms
Diclofenac Sodium SR Pellets are pharmaceutical-grade sustained-release multiparticulate pellets containing Diclofenac Sodium, designed for controlled-release oral dosage-form applications. These pellets are suitable for pharmaceutical formulation development, capsule filling and other multiparticulate oral dosage forms requiring a sustained drug-release profile. Diclofenac Sodium has the molecular formula C₁₄H₁₀Cl₂NNaO₂ and a molecular weight of approximately 318.1 g/mol (source: PubChem).
Diclofenac Sodium sustained-release pellets can be manufactured using drug-layering and functional polymer-coating technologies to achieve the required release characteristics. Published formulation literature has described Diclofenac Sodium sustained-release pellets/beads using drug coating followed by a rate-controlling polymer coat and evaluation of the resulting in-vitro drug-release profile.
Key Features
Applications
Why Choose Diclofenac Sodium SR Pellets?
Packaging & Supply
Diclofenac Sodium SR Pellets can be supplied in suitable pharmaceutical packaging for formulation development and bulk manufacturing applications. Packaging configuration, drug loading, pellet characteristics, release profile, quantity and storage requirements should be confirmed according to the applicable product specification and customer requirements.
| Parameter | Specification |
|---|---|
| Appearance | white to off-white crystalline powder |
| Identification | IR & HPLC compliant |
| Assay (HPLC) | 98.0% – 102.0% |
| Loss on Drying | NMT 0.5% |
| Residue on Ignition | NMT 0.1% |
| Total Impurities | NMT 1.0% |
| Water Content | NMT 0.5% |